Close
Publication: FLARE
19 October 2022
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 Ă— 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19
The FLARE trial team have published a paper via PLOS Medicine, which is available to read on their website here:Â